0000899243-22-036077.txt : 20221116
0000899243-22-036077.hdr.sgml : 20221116
20221116214801
ACCESSION NUMBER: 0000899243-22-036077
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221115
FILED AS OF DATE: 20221116
DATE AS OF CHANGE: 20221116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: dEsparbes Eric
CENTRAL INDEX KEY: 0001622268
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39334
FILM NUMBER: 221396723
MAIL ADDRESS:
STREET 1: THERAVANCE, INC.
STREET 2: 951 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIORA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001580063
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273950390
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4330 LA JOLLA VILLAGE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
BUSINESS PHONE: 855-293-2639
MAIL ADDRESS:
STREET 1: 4330 LA JOLLA VILLAGE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
FORMER COMPANY:
FORMER CONFORMED NAME: PROGENITY, INC.
DATE OF NAME CHANGE: 20150617
FORMER COMPANY:
FORMER CONFORMED NAME: ASCENDANT MDX, INC.
DATE OF NAME CHANGE: 20130625
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-15
0
0001580063
BIORA THERAPEUTICS, INC.
BIOR
0001622268
dEsparbes Eric
C/O BIORA THERAPEUTICS, INC.
4330 LA JOLLA VILLAGE DRIVE, SUITE 300
SAN DIEGO
CA
92122
0
1
0
0
Chief Financial Officer
Common Stock
2022-11-15
4
F
0
5194
0.27
D
710122
D
Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 10,474 vested restricted stock units on November 15, 2022.
Includes 6,887 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on May 31, 2021.
/s/ Will Pridgen, Attorney-in-Fact for Eric d'Esparbes
2022-11-16